Palo Santo has announced the closing of its USD$50m (~£134.10m) fund which will go towards a diverse portfolio of businesses developing innovative psychedelic medicines and therapies.
The thematic ETF will track the performance of the Enhanced Consciousness Index – comprised of companies involved in the legal research, development and production of psychedelics...
One company is providing investors with the opportunity to contribute to novel mental health care solutions by participating in the growth of companies in the psychedelics...